pirenzepine has been researched along with Ambulation Disorders, Neurologic in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Putzhammer, A | 1 |
| Heindl, B | 1 |
| Müller, J | 1 |
| Broll, K | 1 |
| Pfeiff, L | 1 |
| Perfahl, M | 1 |
| Hess, L | 1 |
| Koch, H | 1 |
1 other study available for pirenzepine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
[3-D ultrasound-assisted gait analysis of schizophrenic patients. Comparison between conventional neuroleptics and olanzapine].
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Equipment Design; Female; Gait Disorders, Neurol | 2003 |